Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Neuropeptide

Phoenixin

Phoenixin (PNX) is a highly conserved neuropeptide first described in 2013 and processed from the SMIM20 prohormone into 14- and 20-residue forms.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Registry refreshes and identity assessments are separate from scientific content review.

Length
14 aa
Class
Neuropeptide
Function
GPR173 signaling; reproduction, appetite and stress modulation
Context
Reproductive and behavioral neuroendocrine research

A conserved neuropeptide identified in 2013 that potentiates reproductive hormone signaling.

Also known as: PNX · phoenixin-14 · phoenixin-20 · SMIM20

Part of the Neuropeptides & signaling cluster

Overview

Phoenixin (PNX) is a highly conserved neuropeptide first described in 2013 and processed from the SMIM20 prohormone into 14- and 20-residue forms. Signaling through the GPR173 receptor, it is studied for roles in reproduction, appetite, anxiety and energy metabolism. This page is educational and not medical advice.

Source & context

Biological / chemical source: Cleaved from the SMIM20 prohormone (hypothalamus, peripheral tissues)

Primary research or clinical context: Reproductive and behavioral neuroendocrine research

Forms and receptor

Two cleavage sites in SMIM20 yield phoenixin-14 and phoenixin-20. Phoenixin-20 is enriched in the hypothalamus while phoenixin-14 appears peripherally, and both act through the orphan-derived receptor GPR173 to influence gonadotropin signaling.

Broad physiological roles

In the reproductive system phoenixin potentiates luteinizing-hormone secretion and supports oocyte maturation. Research also links it to food intake, anxiolytic and anti-inflammatory effects, sensory processing, memory and energy metabolism, marking it as a multifunctional signaling peptide.

Structure & chemistry

Molecular identity & reference confidence

Reference mass unavailable

Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.

Molecular form
Phoenixin (source record; form not independently established)
Species
Not established by this molecular identity audit
Termini (N / C)
Not specified / Not specified

Average reference mass

Reference policy updated: 2026-10-05

Clinical development snapshot

ClinicalTrials.gov lists 1 registered study with “Phoenixin” as an intervention (snapshot 2026-09-06). A registry footprint is not evidence of efficacy or approval.

Registered studies
1
Highest phase reached
—
Active in latest 100
0
Most recent update
2026-01-13
Most recently updated studies
NCTTitlePhaseStatusUpdated
NCT07004556The Effect of Laparoscopic Sleeve Gastrectomy on Blood Phoenixin-14 Levels—completed2026-01-13
See all on ClinicalTrials.gov →

FAQ about Phoenixin

What is Phoenixin?+

Phoenixin (PNX) is a highly conserved neuropeptide first described in 2013 and processed from the SMIM20 prohormone into 14- and 20-residue forms. Signaling through the GPR173 receptor, it is studied for roles in reproduction, appetite, anxiety and energy metabolism. This page is educational and not medical advice.

What Canadian product status is recorded for Phoenixin?+

Canadian product status for Phoenixin has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the typical length of Phoenixin?+

Phoenixin is commonly described as approximately 14 amino acids (Neuropeptide).

Related peptides

References & further reading

  1. 1.Billert et al. (2020). Phoenixin: More than Reproductive Peptide. Int J Mol Sci
  2. 2.Mcilwraith et al. (2018). Phoenixin: uncovering its receptor, signaling and functions. Acta Pharmacol Sin
  3. 3.Kulinska et al. (2021). Phoenixin as a New Target in the Development of Strategies for Endometriosis Diagnosis and Treatment. Biomedicines
  4. 4.McIlwraith et al. (2022). The Regulation of Phoenixin: A Fascinating Multidimensional Peptide. J Endocr Soc
  5. 5.Liang et al. (2022). Regulation and physiological functions of phoenixin. Front Mol Biosci
  6. 6.Pałasz et al. (2021). Modulatory effect of olanzapine on SMIM20/phoenixin, NPQ/spexin and NUCB2/nesfatin-1 gene expressions in the rat brainstem. Pharmacol Rep
  7. 7.Schalla et al. (2019). The role of phoenixin in behavior and food intake. Peptides
  8. 8.Ozdemir-Kumral et al. (2022). Phoenixin 14 ameloriates pancreatic injury in streptozotocin-induced diabetic rats by alleviating oxidative burden. J Pharm Pharmacol
  9. 9.PMC — Phoenixin: More than a Reproductive Peptide
  10. 10.Wikipedia — SMIM20 (phoenixin prohormone)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Phoenixin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.